Jgp Global Gestao De Recursos Ltda. Aerie Pharmaceuticals Inc Transaction History

Jgp Global Gestao De Recursos Ltda.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$28.97 - $48.21 $246,911 - $410,893	-8,523 Closed	0 $0
Q1 2019 Apr 24, 2019	BUY	$36.32 - $49.25 $29,056 - $39,400	800 Added 10.36%	8,523 $405,000
Q4 2018 Jan 23, 2019	BUY	$33.0 - $60.04 $254,859 - $463,688	7,723 New	7,723 $279,000
Q2 2018 Aug 10, 2018	SELL	$47.85 - $70.45 $662,435 - $975,309	-13,844 Closed	0 $0
Q1 2018 Apr 17, 2018	BUY	$51.15 - $61.0 $67,927 - $81,008	1,328 Added 10.61%	13,844 $751,000
Q4 2017 Feb 01, 2018	SELL	$50.85 - $65.1 $67,528 - $86,452	-1,328 Reduced 9.59%	12,516 $748,000
Q3 2017 Nov 09, 2017	BUY	$48.6 - $60.1 $672,818 - $832,024	13,844	13,844 $673,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Jgp Global Gestao De Recursos Ltda., based on Form 13F filings with the SEC.

Stay updated on Jgp Global Gestao De Recursos Ltda. with notifications on news.